BIOMARKERS: Improving Patient Access to Targeted Cancer Therapies hosted by CSBA
Precision medicine uses information about a person's own genes or proteins to prevent, diagnose, or treat disease. When used in the treatment of cancer, precision medicine incorporates specific information about a person's cancer to inform diagnosis, prognosis, therapy selection, and how to monitor how well therapy is working. Biomarkers are an essential part of precision medicine, and biomarker testing can help determine the best treatment plan for a specific patient.
John Conrad, President & CEO, iBio
Hilary Gee Goeckner, MSW, Senior State and Local Campaigns Manager - Medicaid, ACS CAN
Nadia Haque, Biomarker Testing Account Executive, Genentech